Illumina, General Atlantic and Viking Global have supplied $70m for Ginkgo Bioworks, an MIT spinout that has now raised more than $789m altogether.

Ginkgo Bioworks, a US-based microbe engineering services spinout of Massachusetts Institute of Technology, has received $70m in funding from genomics technology producer Illumina, growth equity firm General Atlantic and hedge fund manager Viking Global Investors. Founded in 2009, Ginkgo has developed cell programming technology that is capable of growing organisms for industrial applications such as…

The rest of this content is only accessible to University Venturing: News, Data and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.